![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2020
Anzahl der Publikationen: 1
2020
Smolen, Josef S.; Mease, Philip; Tahir, Hasan; Schulze-Koops, Hendrik; de la Torre, Inmaculada; Li, Lingnan; Hojnik, Maja; Sapin, Christophe; Okada, Masato; Caporali, Roberto; Gratacos, Jordi; Goupille, Philippe; Liu Leage, Soyi; Pillai, Sreekumar und Nash, Peter
(2020):
Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naive to biological disease-modifying antirheumatic drug: final results by week 52.
In: Annals of the Rheumatic Diseases, Bd. 79, Nr. 10: S. 1310-1319
[PDF, 2MB]